The Department of the Navy hereby gives notice of its intent to grant to Epitracker, LLC, a revocable, nonassignable, partially exclusive license in the United States to practice the Government-Owned inventions described in U.S. Patent Application No. 14/591660--``Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome''.
Document
Notice of Intent To Grant Partially Exclusive Patent License; Epitracker, LLC
The Department of the Navy hereby gives notice of its intent to grant to Epitracker, LLC, a revocable, nonassignable, partially exclusive license in the United States to practic...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 26236
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Notice of Intent To Grant Partially Exclusive Patent License; Epitracker, LLC,” thefederalregister.org (May 7, 2015), https://thefederalregister.org/documents/2015-10990/notice-of-intent-to-grant-partially-exclusive-patent-license-epitracker-llc.